Founder, President & CEO
Robert DiCrisci is the President, CEO of NextSource Biotechnology (NSB), a sister company of Amatheon Pharmaceuticals. Mr. DiCrisci has over 15 years of experience in the
healthcare and pharmaceuticals industry as an Operations and Technology Executive. As the President, CEO Mr. DiCrisci is responsible for implementing the company vision and overall
business strategy to advance the company’s mission statement, Corporate Objectives, and to promote revenue growth, and profitability. Additionally, Mr. DiCrisci is responsible for
the high level guidance of all company Sales and Operational direction in line with the Corporate Objectives.
Mr. DiCrisci is the Licensed DEA Registrant for all regulatory afford. He has successfully held Executive Management positions working in both the Public and Private Sector.
His experience includes holding positions as CEO, COO, CIO, Operations Director and Executive IT Director. These positions were held separately for the following businesses
– Medical Staffing Network, Cosabella Inc., Health Coalition, University of Michigan Health Systems, AAA Auto Club Group, HRH Construction, and Sirco Associates.
Prior to holding the above management positions he was a Microsoft Systems Engineer and Programming consultant. Robert also holds the following certifications and licenses:
Project Management Institutes highly regarded Business PMP License as a Project Management Professional. Additionally, early in Mr. DiCrisci’s career he served as an Engineer
and acquired his MCSE CNA & CCNP Designations.
Chris F. Yankana
Chief Financial Officer
Chris Yankana is the Chief Financial Officer of NextSource Biotechnology (NSB). Mr. Yankana has over 20 years of experience in the healthcare and pharmaceutical industry as
CFO, Controller, Auditor and Sales Manager. As the CFO for NextSource, he plays a vital role in developing and implementing the national strategies, financial planning, purchasing
programs. He also serves as an advisor to all department including the Sales/Marketing initiatives. He is responsible for overseeing all fiscal and fiduciary responsibilities for
NextSource Biotechnology and its subsidiaries.
Mr. Yankana is the Resident Certified Designated Representative and is also a Certified Public Accountant (CPA). His experience includes positions as the Controller then Sales Manager for Health Coalition; prior to this he served
as an Accounting Auditor for several large NYC companies.
Executive Vice President
As the Executive Vice President, Mr. Charria brings to the table a wealth of knowledge with over 13 years of Executive management experience in industries such as Healthcare,
Pharmaceuticals, Aerospace, Transportation and Logistics. This has given him the necessary tools to operate as NextSource’s Executive Vice President. Mr. Charria is responsible
for executing the corporate business plans to efficiently optimize the organization. He is also responsible for overseeing the management of short term and long term corporate
goals. Mr. Charria undertakes a strategic role in every aspect of our business development process and reports to directly to the CEO in implementing, executing and delegating
all corporate objectives. He has produced outstanding and innovative results that have allowed him to excel throughout his career.
Carlos Charria – BS, graduated with honors from Embry-Riddle Aeronautical University with a Bachelors of Science in Management of Technical Operations. Carlos has also held Executive
Management positions working in both the Public and Private Sectors for several FORTUNE 500 companies. His experience includes positions as a Senior Sales Manager, Logistics Manager,
Regional Sales Manager, Senior Operations Manager and Executive Director of Business Development for companies such as – FedEx Inc., Enterprise Inc., Medical Staffing Network, LLC,
Amatheon Inc., Apex Aerospace Solutions Inc., and currently NextSource Biotechnology (NSB).
Kevin A. Hahn, DVM, PhD, DACVIM
Chief Scientific Officer, Executive Vice President
Kevin A. Hahn, DVM, PhD, DACVIM (Oncology) is Chief Scientific Officer and Executive Vice President for NextSource Biotechnology (NSB). Dr. Hahn has over 25 years of experience in the
veterinary healthcare, nutrition, and pharmaceutical industry. As CSO he leads the NextSource Biotechnology global new product pre-clinical development and regulatory approval strategy and
serves as a key advisor during the development and implementation of Sales/Marketing initiatives.
Prior to joining NextSource Biotechnology he served as Chief Medical Officer for Hill’s Pet Nutrition, Inc. (Topeka, KS); Senior Partner for Gulf Coast Veterinary Oncology & Diagnostic Imaging
(Houston, TX); and Associate Professor of Medical Oncology, University of Tennessee (Knoxville, TN).
Dr. Hahn is an entrepreneur, scientist, veterinarian, and community supporter. He actively participates in causes that enrich the human-animal bond as well as the human-spiritual bond.
He is recognized internationally in the discipline of veterinary medical oncology, companion animal nutrition, comparative biosciences, and is an active leader in the animal health industry.
Richard C. Dinovitz
Senior Vice President of Business Development
As an officer-level executive, Richard has extensive leadership success working in complex Fortune 500 companies in the pharmaceutical industry, including working with
the CDC and navigating the Government/Public sectors. He has a diverse functional background in strategic sales, marketing, specialty, vaccine and biological,
oncological/anti-infective product marketing, business development, sales management, and commercial operations − and has consistently demonstrated the ability
to deliver strong and sustainable financial gains through building high performing teams, identifying/capitalizing on business and product specification opportunities,
expanding distribution channels, launching of new products, and developing innovative marketing strategies. Additionally, he has gained considerable expertise in
government negotiation, commercial operations, strategic alliance management, and contracting.
Richard built a successful team, led Business Development, Marketing and Sales at Nuron Biotech. He was successful in acquiring five products in less than two
years and ensured the successful financing of the company.
Following a highly successful 32 year career with the Pfizer/Wyeth/Lederle acquisition trail, Richard is currently the President and COO of RCDVaccine, LLC and the
Owner of Vaccine Business Logistics. He founded his current companies to increase product access, exposure, and immunization rates; provide brokerage of products
and services; and offer exemplary consulting services to providers, manufacturers, and suppliers to meet commercial or philanthropic goals.
Leaving Pfizer in May 2010 following its acquisition of Wyeth Pharmaceuticals in late 2009, Richard was Executive Director, National Sales, where he led the sales
team to maximize sales opportunities, revenue, and market share through high-impact strategic analysis and implementation, capture and retain major accounts, and
cultivate relationships with key opinion leaders/decision makers in academic medical centers and managed markets. His previous positions at Wyeth included Senior
Director of Sales; Director, National Pediatric Programs and Industry Affairs; Director, Customer Relations; and Field Sales Director, National Accounts.
Prior to Wyeth, Richard had been with Lederle Laboratories for 16 years in various, increasingly responsible Sales Management positions − his last two roles
being Senior Sales Manager, Corporate Trade Relations and National Account Sales Manager.
Richard received his B.S degree from the University of Pittsburgh. He is Certified Medical Representative Institute, a Member of the Cardinal Advisory Board,
and an active participant in NACDS, HDMA, FMI trade associations.
Director of Strategic Planning & Market Access
Mr. Armand brings over 30 years of executive experience in the pharmaceutical industry. He has extensive knowledge and understanding of the industry across numerous therapeutic areas including
Dermatology, Hematology/Oncology, specifically in; Lymphomas/Leukemia’s, Genitourinary, Gynecological, Colorectal Head and Neck and Breast Cancers. As Director of Strategic Planning and Market
Access he is responsible for identifying and implementing programs which support our portfolio of products by all stakeholders. He also works across platforms, both internal and external,
to ensure flawless execution of our Access Strategy. Mr. Armand was instrumental during the formative phase of the company by helping to develop the structural foundation of NextSource Biotechnology.
Raul Armand graduated from Florida State University with a Bachelor of Business Administration in Marketing and Communications. During his stellar career at Bristol-Myers Squibb in Direct
Marketing and Training he won numerous awards and was inducted into “Grand Master.” Throughout the years he served as a mentor to many colleagues and as a consultant to senior management
and brand agencies. Raul lives in Miami, is married and has two daughters, he volunteers his time and talents with a local Non-Profit helping orphaned and abandoned children.